Skip to main content
DNTH logo

DNTH · Dianthus Therapeutics, Inc. /DE/ · Analyst Estimates

Track DNTH — free
$90.10 +2.05 (+2.33%)
Market Cap
$5.23B
Shares
55.93M
Volume · Oct 1 123.29K Avg daily vol (3M) 833.35K

Analyst Estimates

Compare analyst forecasts for Dianthus Therapeutics, Inc. /DE/ across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-30 17:29 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-4.1
-3.81404
-3.43003
—
-3.92
-3.92667
-3.81404
-3.92667
— — — —
EPS
analysts
Publication date not stated
— — —
11
— — — —
1
1
2
2
Revenue
USD
Publication date not stated
900000
1869860
3224000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
14
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-5.77
-4.61098
-3.47334
—
-4.74333
-4.65111
-4.61098
-4.65111
— — — —
EPS
analysts
Publication date not stated
— — —
11
— — — —
1
1
2
2
Revenue
USD
Publication date not stated
0
1774880
6000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
14
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-1.13
-0.94865
-0.3929
—
-1.02
-1.0225
-0.94865
-1.0225
— — — —
EPS
analysts
Publication date not stated
— — —
10
— — — —
1
1
2
2
Revenue
USD
Publication date not stated
0
366420
1000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
14
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-1.36
-1.11174
-0.9841
—
-1.14
-1.18
-1.11174
-1.18
— — — —
EPS
analysts
Publication date not stated
— — —
10
— — — —
1
1
2
2
Revenue
USD
Publication date not stated
0
281190
1000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
14
— — — — — — — —
Key facts CIK 1690585 CUSIP 252828108 13F (30d) 8 filings 8 filers Visit website Investor relations